病因学
回顾性队列研究
医学
肺炎支原体
病菌
多中心研究
内科学
支原体
病例对照研究
儿科
重症监护医学
免疫学
流行病学
作者
Xufeng Li,Pan Li,Z C Li,Yating Li,Lifen Yang,Xiaolu Ye,Asimuguli Wubuli,Qiqing Ye,Fangxuan Yang,Hui Yi,Riziwanguli Maitusong,Yuejin Liang,Yun Cai,Zhuang‐Gui Chen
标识
DOI:10.1016/j.ijid.2025.108230
摘要
OBJECTIVES: Co-detection are frequent in pediatric Mycoplasma pneumoniae pneumonia (MPP), yet their full pathogen spectrum and clinical impact remain incompletely characterized. This study aimed to characterize co-detection etiology and clinical impacts of MPP in hospitalized children. METHODS: A multicenter retrospective cohort study was conducted among hospitalized children under 14 years with MPP, diagnosed by metagenomic or targeted next-generation sequencing of bronchoalveolar lavage fluid, from June 2023 to July 2024. Multivariate logistic regression models were used to assess differences in clinical characteristics among various Mycoplasma pneumoniae (MP) co-detection patterns. RESULTS: Among 570 MPP cases, co-detection occurred in 338 (59.3%) cases: viral-only (29.3%), bacterial-only (30.2%), and viral-bacterial (40.5%). The main bacteria were Streptococcus pneumoniae and Haemophilus influenzae, while human adenovirus and Epstein-Barr virus were the most common viruses. Co-detection rates inversely correlated with age, decreasing from 91.1% in infants to 48.1% in adolescents. Younger age (36-72 mo vs 72-168 mo, OR: 1.57), non-summer seasons (Spring, OR: 2.44; Autumn, OR: 1.93; Winter, OR: 2.77), and elevated white blood cell count (OR: 1.18) were associated with higher risk of co-detection, whereas higher fibrinogen and pleural effusion reduced risk (all P < 0.01). CONCLUSIONS: The high prevalence of co-detection in pediatric MPP, notably viral-bacterial, exhibits distinct age and seasonal patterns essential for informing targeted control strategies. Study limitations include its retrospective design and potential heterogeneity from multicenter differences in NGS methodologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI